Effect of Lifei Yishen-recip on Lung Function of COPD Grade Ⅲ

ZHANG Xiao-mei; YIN Ting; YANG Xiao-hua; WU Hai-bin; YAO Jin-fang

您当前的位置：

首页 >

文章列表页 >

Effect of Lifei Yishen-recip on Lung Function of COPD Grade Ⅲ

更新时间：2024-01-04

- Effect of Lifei Yishen-recip on Lung Function of COPD Grade Ⅲ
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 2, Pages: 289-291(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
ZHANG Xiao-mei, YIN Ting, YANG Xiao-hua, et al. Effect of Lifei Yishen-recip on Lung Function of COPD Grade Ⅲ[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(2): 289-291.
DOI：

ZHANG Xiao-mei, YIN Ting, YANG Xiao-hua, et al. Effect of Lifei Yishen-recip on Lung Function of COPD Grade Ⅲ[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(2): 289-291. DOI：

摘要

目的: 评价中药理肺益肾方治疗慢阻肺缓解期的疗效。方法: 选择Ⅲ级慢性阻塞性肺病(COPD)患者60例

随机分为观察组和对照组各30例

观察组给予中药理肺益肾方汤药治疗

对照组采用西药沙美特罗替卡松吸入和口服氨茶碱剂量治疗

治疗疗程3个月。结果: 理肺益肾方组与西药组均能显著改善症状、提高肺功能

组间比较无差异

理肺益肾方组肺感染和感冒次数较激素组显著减少

P<0.01。结论: 理肺益肾方能有效治疗慢阻肺缓解期

且用药安全。

Abstract

Objective: Tostudy effect of Lifei Yishen-recipon chronic obstructive pulmonary disease (COPD) of patients. Method: Sixty COPD paitents of grade Ⅲ were randomly divided into 2 groups

the treatment group with 30 cases received Chinese medeicen Lifei Yishen-recip; the control group with 30 cases received routine westen medical treatment

the treatment time lasted 3 months. Result: Two groups can improve symptoms and enhance lung ventilation function. Lifei Yishen-recip can obviously releaes commen cold and infection of lung. Conclusion: Lifei Yishen-recip has effect on COPD.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰